September 12, 2025 a 07:43 pm
MRK: Fundamental Ratio Analysis - Merck & Co., Inc.
Merck & Co., Inc., a global healthcare company, operates in both pharmaceutical and animal health segments. With a comprehensive range of products and strategic collaborations, Merck is well-positioned in the healthcare market. The stock shows mixed performance based on recent fundamentals and analyst ratings.
Fundamental Rating
Merck's fundamental data reveals a strong financial health with moderate growth potential. Overall, the company has earned a solid rating, though some areas like debt management could be improved.
| Category | Score | Visualization |
|---|---|---|
| Overall | 4 | |
| Discounted Cash Flow | 5 | |
| Return on Equity | 5 | |
| Return on Assets | 5 | |
| Debt to Equity | 1 | |
| Price to Earnings | 2 | |
| Price to Book | 2 |
Historical Rating
The historical data reflects the consistency in Merck's performance but highlights potential fluctuations in market perception over time.
| Date | Overall | DCF | ROE | ROA | D/E | P/E | PB |
|---|---|---|---|---|---|---|---|
| 2025-09-12 | 4 | 5 | 5 | 5 | 1 | 2 | 2 |
| Previous | 0 | 5 | 5 | 5 | 1 | 2 | 2 |
Analyst Price Targets
Analysts provide a positive outlook with price targets indicating potential growth, supported by a consensus to buy.
| High | Low | Median | Consensus |
|---|---|---|---|
| $98 | $82 | $90 | $90 |
Analyst Sentiment
Analyst sentiment remains favorable with a predominant recommendation to buy, suggesting strong market confidence in Merck's future performance.
| Rating | Number of Recommendations | Distribution |
|---|---|---|
| Strong Buy | 0 | |
| Buy | 25 | |
| Hold | 9 | |
| Sell | 1 | |
| Strong Sell | 0 |
Conclusion
Merck & Co., Inc. demonstrates a solid fundamental rating, with strong analyst support signaling confidence in its future prospects. However, the company's debt management needs attention to enhance overall financial health. Given market competition and evolving healthcare needs, Merck's strategic position and diversified segments offer both growth opportunities and challenges. Investors should weigh the potential for high returns against the required risk mitigation strategies.